Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS for Sentinel Node Detection in Melanoma, Breast Cancer or Head & Neck Cancer
NCT07310758Phase 3Recruiting
- Sponsor
- Netherlands Cancer Institute
- Start
- Sep 2025
- Primary completion
- Sep 2026
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
A Phase 3 trial of sonazoid in melanoma, breast cancer, head and neck cancer (HNC), sponsored by Netherlands Cancer Institute. Started Sep 2025; status: recruiting.
02
Drugs
sonazoid
03
Conditions
melanomabreast cancerhead and neck cancer (HNC)
Beyond the preview
Go deeper on NCT07310758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07310758.